Myxoma Virus Induces Apoptosis in Cultured Feline Carcinoma Cells
Overview
Authors
Affiliations
There is growing interest in utilizing replicating oncolytic viruses as cancer therapeutics agents. The effectiveness of myxoma virus-induced oncolysis was evaluated in two feline cancer cell cultures. Although myxoma virus is a rabbit-specific pathogen, protein expression driven by myxoma virus and production of infectious viral particles were detected. Cell death occurred in primary feline cancer cells within 48 h of inoculation with myxoma virus. Future studies to determine if other feline neoplasms are susceptible to myxoma virus infection are warranted.
Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma.
Ashton L, Weishaar K, Seguin B, MacNeill A Biomedicines. 2023; 11(9).
PMID: 37760788 PMC: 10525839. DOI: 10.3390/biomedicines11092346.
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.
Ashton L, Graham B, Afzali M, Gustafson D, MacNeill A Oncolytic Virother. 2020; 9:17-29.
PMID: 32548076 PMC: 7266523. DOI: 10.2147/OV.S252727.
Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
Ashton L, Quackenbush S, Castle J, Wilson G, McCoy J, Jordan M Viruses. 2020; 12(5).
PMID: 32397134 PMC: 7290507. DOI: 10.3390/v12050517.
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.
Conrad S, Liu J Methods Mol Biol. 2019; 1937:189-209.
PMID: 30706397 PMC: 6855597. DOI: 10.1007/978-1-4939-9065-8_11.
Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
MacNeill A, Weishaar K, Seguin B, Powers B Viruses. 2018; 10(8).
PMID: 30060548 PMC: 6115854. DOI: 10.3390/v10080398.